These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7913784)

  • 1. Long-term management of variceal bleeding: the place of pharmacotherapy.
    Lebrec D
    World J Surg; 1994; 18(2):229-32. PubMed ID: 7913784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
    Villanueva C; Miñana J; Ortiz J; Gallego A; Soriano G; Torras X; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
    N Engl J Med; 2001 Aug; 345(9):647-55. PubMed ID: 11547718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological methods for the prevention of first and recurrent bleeding from esophagogastric varices.
    Fleig WE
    Z Gastroenterol; 1988 Sep; 26 Suppl 2():40-8. PubMed ID: 2903596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
    Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
    Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: pharmacotherapeutic agents in the treatment of portal hypertension.
    Lebrec D
    J Gastroenterol Hepatol; 1997 Feb; 12(2):159-66. PubMed ID: 9083918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of value of propranolol in prevention of variceal haemorrhage.
    Hayes PC; Davis JM; Lewis JA; Bouchier IA
    Lancet; 1990 Jul; 336(8708):153-6. PubMed ID: 1973480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
    Bosch J
    P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial.
    Gatta A; Merkel C; Sacerdoti D; Bolognesi M; Caregaro L; Zuin R; Angeli P; Ruol A
    Digestion; 1987; 37(1):22-8. PubMed ID: 3301478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker plus nitrate for primary prophylaxis of variceal bleeding.
    Assi SA; Sanyal A; Schubert ML
    Gastroenterology; 2000 Oct; 119(4):1170-2. PubMed ID: 11040207
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers in the prevention of gastrointestinal bleeding.
    Lebrec L
    Rev Invest Clin; 1990 Jul; 42 Suppl():159-64. PubMed ID: 19256157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
    Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological therapy for portal hypertension: rationale and results.
    Burroughs AK; Panagou E
    Semin Gastrointest Dis; 1995 Jul; 6(3):148-64. PubMed ID: 7551972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
    Villanueva C; Balanzó J; Novella MT; Soriano G; Sáinz S; Torras X; Cussó X; Guarner C; Vilardell F
    N Engl J Med; 1996 Jun; 334(25):1624-9. PubMed ID: 8628357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of first variceal bleeding: new prospects.
    Hamid S; Jafri W
    J Pak Med Assoc; 1992 Feb; 42(2):47-51. PubMed ID: 1349361
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-adrenergic antagonists for primary prevention of gastrointestinal hemorrhage in patients with cirrhosis and esophageal varices.
    Elder CA; Restino MS
    Clin Pharm; 1992 Apr; 11(4):337-41. PubMed ID: 1563229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.